August 3, 2023

Anup Misra Discusses the Opportunities for Funding in Life Sciences IP

In a recent article from Managing IP on the increase in demand for financing in life sciences IP, Director Anup Misra discussed that he is seeing more requests for funding in that sector than in previous years.

According to Misra, “More life sciences companies are beginning to look at funding as an avenue to enforce their IP. It’s a lot more mainstream. More law firms are educated about it and it’s in the press.”

Misra went on to add that life science companies that have broader portfolios are beginning to seek out more ways to monetize them, which litigation funding can help with. He also discussed how life science plaintiffs more regularly sue smaller players than high-tech plaintiffs do, which means defendants will need enough resources to pay damages and settlements.

Learn more here.

Curiam Capital

Curiam Capital

Curiam Capital is a private investment firm that provides financing for high-value litigation. Curiam specializes in finding flexible and creative solutions that allow parties to hire the lawyers of their choice to pursue strong legal claims. Learn More